Bank of America Lowers PO On Human Genome Sciences To $13

Symbols: HGSI
Share

Bank of America has lowered the price objective on Human Genome Sciences (NASDAQ: HGSI) from $24 to $13 and maintains its Underperform rating.


 
 
< Previous
Bank of America Lowers PO On Dendreon To $12
Next >
Jefferies Upgrades Materion To Buy, Lowers PT To $44
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust